At a glance
ClinicalIndex Comparison RecordN/ACompleted· 290 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety Profile of Aprotinin in Neonates Undergoing Cardiopulmonary Bypass: A Retrospective Chart Review
In Brief
An observational study for Cardiopulmonary Bypass and 2 related conditions. Completed, enrolled 290 participants across 1 site.
Detailed Summary
This is a retrospective chart review study. The purpose of this study is to review our experience at Children's Healthcare of Atlanta in neonates receiving aprotinin. We will examine the specific outcomes of renal dysfunction, thrombosis and mortality.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiopulmonary Bypass, Congenital Defects, Hemostasis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2007
First PostedMay 2007
Study CompletionDec 2008
TodayJul 2026
First PostedMay 4, 2007
Enrollment StartApr 1, 2007
Study CompletionDec 1, 2008
TodayJul 2, 2026
Posted 19.2 years ago